Biofil Chemicals & Pharmaceuticals Limited — Board Meeting, 30-05-2025: Outcome of Board Meeting

Biofil Chemicals and Pharmaceuticals has announced a board meeting approving the audited financial results for the quarter and financial year ended March 31, 2025. The company posted revenue of ₹85.88 Cr for the quarter and ₹337.07 Cr for the year. Profit before tax was ₹0.25 Cr for the quarter and ₹0.74 Cr for the year, with net profit at ₹0.20 Cr and ₹0.56 Cr, respectively. The audit came through clean. Equity stands steady at ₹16.27 Cr with manageable liabilities. No dividend declared or major strategic updates shared.